GTG China Announcement 27/03/19 PRICE SENSITIVE Share GTG Trading Halt 27/03/19 PRICE SENSITIVE Share GTG Pause in Trading 27/03/19 PRICE SENSITIVE Share GTG Investor Presentation 19 March 2019 20/03/19 PRICE SENSITIVE Share GTG Half Yearly Report and Accounts 27/02/19 PRICE SENSITIVE Share GTG ASX Lodgement Supplementary Prospectus 18/02/19 PRICE SENSITIVE Share GTG GTG US and UK Research Collaboration 01/02/19 PRICE SENSITIVE Share GTG Quarterly Update and 4C 30/01/19 PRICE SENSITIVE Share GTG End of Year R&D Update 21/12/18 PRICE SENSITIVE Share GTG Blockshine Health ASX Announcement 21/12/18 PRICE SENSITIVE Share GTG 2018 Annual General Meeting materials 29/11/18 PRICE SENSITIVE Share GTG Lodgement Prospectus and Appendix 3B 19/11/18 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C - 30 Sept. 2018 30/10/18 PRICE SENSITIVE Share GTG GTG Invited to Establish Market Presence in Hainan, China 17/09/18 PRICE SENSITIVE Share GTG Appendix 4E and Financial Report 2018 30/08/18 PRICE SENSITIVE Share GTG Hainan Invitation to discuss Market Entry into China 21/08/18 PRICE SENSITIVE Share GTG Proposed JV with Beijing Zishan Health Consultancy Limited 16/08/18 PRICE SENSITIVE Share GTG Lodgement of Prospectus and Appendix 3B 08/08/18 PRICE SENSITIVE Share GTG Genetic Technologies Secures A$20M Equity Placement Facility 08/08/18 PRICE SENSITIVE Share GTG Swisstec Update 07/08/18 PRICE SENSITIVE Share GTG Formalisation of Strategic Alliance with Blockchain Global 02/08/18 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C - 30 June 2018 31/07/18 PRICE SENSITIVE Share GTG Expansion of Genetic Risk Assessment Tests 16/07/18 PRICE SENSITIVE download Created with Sketch. 423.46KB Share GTG Swisstec Heads of Agreement 19/06/18 PRICE SENSITIVE download Created with Sketch. 613.77KB Share GTG Binding Project Shivom Agreement 07/06/18 PRICE SENSITIVE download Created with Sketch. 442.28KB Share GTG NHMRC Partnership Grant Awarded 01/05/18 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C - 31 March 2018 30/04/18 PRICE SENSITIVE Share GTG Research Agreement - Enhancement of Breast Cancer Risk Test 16/03/18 PRICE SENSITIVE Share GTG Project Shivom Strategic Alliance 06/03/18 PRICE SENSITIVE Share GTG Appendix 4D & Half Year Financial Report - 31 December 2017 27/02/18 PRICE SENSITIVE Share GTG Reinstatement to Official Quotation 15/02/18 PRICE SENSITIVE Share GTG Strategic Alliance and Capital Raising 15/02/18 PRICE SENSITIVE Share GTG Change of Chief Executive Officer 06/02/18 PRICE SENSITIVE Share GTG Voluntary Suspension from Official Quotation 31/01/18 PRICE SENSITIVE Share GTG Results from 31 January 2018 General Meeting 31/01/18 PRICE SENSITIVE Share GTG Trading Halt 30/01/18 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C - 31 December 2017 29/01/18 PRICE SENSITIVE Share GTG Response to ASX Price Query 21/12/17 PRICE SENSITIVE Share GTG Update on Strategic Review Initiative 12/12/17 PRICE SENSITIVE Share GTG Quarterly Activities Report - 30 September 2017 30/10/17 PRICE SENSITIVE Share GTG Transition to Online Commercial Platform for BREVAGenplus 21/09/17 PRICE SENSITIVE Share GTG Appendix 4E and Financial Report 2017 29/08/17 PRICE SENSITIVE Share GTG Comprehensive Review of Strategic Alternatives 25/08/17 PRICE SENSITIVE Share GTG Breast Cancer Awareness Month Promotion for BREVAGenplus 01/08/17 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C - 30 June 2017 27/07/17 PRICE SENSITIVE Share GTG Nasdaq Deficiency Notice 21/07/17 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C - 31 March 2017 27/04/17 PRICE SENSITIVE Share GTG Change in Pricing and Billing Program 31/03/17 PRICE SENSITIVE Share GTG Partnership to Promote BREVAGenplus, Second Year 29/03/17 PRICE SENSITIVE Share GTG Appendix 4D and 31 December 2016 Half Year Financial Report 23/02/17 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C - 31 December 2016 27/01/17 PRICE SENSITIVE Share GTG AUD 8.1 Million Capital Raising 02/12/16 PRICE SENSITIVE Share GTG License Agreement to Develop Colorectal Cancer Risk Test 29/11/16 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C, 30 September 2016-GTG.AX 27/10/16 PRICE SENSITIVE Share GTG Appendix 4E & Financial Report 2016-GTG.AX 29/08/16 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C - 30 June 2016-GTG.AX 28/07/16 PRICE SENSITIVE Share GTG Quarterly Activities Report & Appendix 4C-GTG.AX 28/04/16 PRICE SENSITIVE Share GTG Appendix 4D and 31 December 2015 Half Year Financial Report 24/02/16 PRICE SENSITIVE Share GTG Partnership to promote BREVAGenplus 22/02/16 PRICE SENSITIVE Share GTG Appendix 4C - 31 December 2015 27/01/16 PRICE SENSITIVE Share GTG Key Scientific Results in Support of Brevagenplus 21/12/15 PRICE SENSITIVE Share GTG African-American and Hispanic Validation Study 23/11/15 PRICE SENSITIVE Share GTG Response to ASX Price and Volume Query 05/11/15 PRICE SENSITIVE Share GTG Appendix 4C - 30 September 2015 29/10/15 PRICE SENSITIVE Share GTG 2015 Appendix 4E - Preliminary Financial Report 28/08/15 PRICE SENSITIVE Share GTG US Patent Office grants key BREVAGENplus Patents 06/08/15 PRICE SENSITIVE Share GTG Appendix 4C - 30 June 2015 31/07/15 PRICE SENSITIVE Share GTG Pathway to Peer Review Publication 14/07/15 PRICE SENSITIVE Share GTG GTG supports research findings 29/05/15 PRICE SENSITIVE Share GTG Quarterly Activites Report - 31 March 2015 27/04/15 PRICE SENSITIVE Share GTG Response to ASX Price Query 31/03/15 PRICE SENSITIVE Share GTG Supplementary Prospectus 13/03/15 PRICE SENSITIVE Share GTG AUD $18.6 Million Capital Raising 06/03/15 PRICE SENSITIVE Share GTG Trading Halt 06/03/15 PRICE SENSITIVE Share GTG ASX Appendix 4D - 31 December 2014 27/02/15 PRICE SENSITIVE Share GTG Appointment of CEO 26/02/15 PRICE SENSITIVE Share GTG Response to Price Query 12/02/15 PRICE SENSITIVE Share GTG Quarterly Activities Report - 31 December 2014 30/01/15 PRICE SENSITIVE Share GTG New Centre Adoption 29/01/15 PRICE SENSITIVE Share GTG Prospectus 22/01/15 PRICE SENSITIVE Share GTG Standby Equity Placement Facility 22/01/15 PRICE SENSITIVE Share GTG Clinical Validation Supporting BREVAGenplus 17/12/14 PRICE SENSITIVE Share GTG Proposed Share Purchase Plan (SPP) 03/12/14 PRICE SENSITIVE Share GTG Intention of Board to offer Share Purchase Plan 25/11/14 PRICE SENSITIVE Share GTG Key Managerial Appointments following the Resignation of CEO 25/11/14 PRICE SENSITIVE Share GTG Divestment of Australian heritage business completed 19/11/14 PRICE SENSITIVE Share GTG Quarterly Reports - September 30 2014 28/10/14 PRICE SENSITIVE Share GTG BREVAGen test numbers - September quarter 2014 06/10/14 PRICE SENSITIVE Share GTG New Generation Test - BREVAGenplus Launch 01/10/14 PRICE SENSITIVE Share GTG Reinstatement to Official Quotation 15/09/14 PRICE SENSITIVE Share GTG Financing and Restructure Plan Finalised 15/09/14 PRICE SENSITIVE Share GTG Suspension from Official Quotation 11/09/14 PRICE SENSITIVE Share GTG Trading Halt 09/09/14 PRICE SENSITIVE Share GTG ASX Appendix 4E - 30 June 2014 29/08/14 PRICE SENSITIVE Share GTG Further Patent Success in USA 26/08/14 PRICE SENSITIVE Share GTG Quarterly Reports - 30 June 2014 31/07/14 PRICE SENSITIVE Share GTG Return to growth in BREVAGen test numbers 04/07/14 PRICE SENSITIVE Share GTG Completion of share transactions with Dr. Mervyn Jacobson 16/05/14 PRICE SENSITIVE Share GTG Quarterly Reports - 31 March 2014 30/04/14 PRICE SENSITIVE Share GTG Settlement with Promega Corporation 24/03/14 PRICE SENSITIVE Share
3.9¢
(20min delay)
